Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EPiTB

Financiado

Cerrado

EPiTB Addressing an unmet need same day diagnosis of extra pulmonary TB in a h...

EPiTB Addressing an unmet need same day diagnosis of extra pulmonary TB in a high burden setting. Better diagnostic approaches are required to improve TB control in Africa, which is suboptimal. One neglected aspect of TB diagnosis is that of extrapulmonary TB (EPTB), which comprises ~15% of the TB caseload. However, in HIV-end... ver más

30/04/2026

UNIVERSITY OF CAPE...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITY OF CAPE TOWN LUNG INSTITUTE PTY LT... No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-25

HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01: Promoting implementation of researc... ExpectedOutcome:This topic aims at supporting activities that contribute to one or several of the ex...

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

UNIVERSITY OF CAPE TOWN LUNG...

2.62M€ | Lider

BRTI

521.27K€ | Participante

Leiden University Medical Ce...

388.32K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PCI2023-143397 Inmunidad, infección e inmunoterapia 100K€ Cerrado

TB PROGNOSIS A progress of tuberculosis and HIV tuberculosis treatment as... 133K€ Cerrado

TB-PATH Novel Approaches to Determine Molecular Mechanisms of Pathog... 2M€ Cerrado

Respiratory-ImmunoDx Clinical validation of host biomarker signature for distingu... 3M€ Cerrado

STOOL4TB Evaluating a new stool based qPCR for diagnosis of tuberculo... 348K€ Cerrado

DEMO-NOPERSIST Demonstration of NOPERSIST results leading to novel validat... 691K€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2023-04-25
Fecha Fin: 2026-04-30

Líder del proyecto

UNIVERSITY OF CAPE TOWN LUNG INSTITUTE PTY LT... No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Better diagnostic approaches are required to improve TB control in Africa, which is suboptimal. One neglected aspect of TB diagnosis is that of extrapulmonary TB (EPTB), which comprises ~15% of the TB caseload. However, in HIV-endemic settings over one third of cases are due to EPTB (the most common manifestation being pleural TB). Frontline same day sputum-based diagnostic tools such as GeneXpert perform poorly when using fluid derived from EPTB-specific compartments (e.g. pleural fluid). Indeed, GeneXpert sensitivity in pleural TB is ~35%. ADA, the current standard of care used in clinical practice has poor specificity, especially in pericardial TB and TB-meningitis (see preliminary data). By contrast, unstimulated interferon-gamma (not T-cell-based IGRAs that require overnight stimulation) is an excellent biomarker for the diagnosis of EPTB (confirmed in 2 meta-analyses). A South African university start-up has now developed a low-cost same-day EPTB diagnostic test (IRISA-TB), which has been evaluated and published in several small clinical trials (see main proposal) and is locked-in for scale-up dissemination in 2022. The test is CE marked, SAHPRA approved, and endorsed by the Global Fund. This proposal encompasses a large prospective multicentric study (n= 2170 patients) of IRISA-TB in various forms of EPTB (pleural, pericardial, and peritoneal TB, and TB meningitis). The proposed study (EPiTB) has excellent fidelity with the EDCTP call because it will enable the registration of a new health technology through pragmatic effectiveness studies, enable uptake of results into clinical practice and facilitate WHO endorsement. Thus, EPiTB will drive the facilitation and uptake of an important new TB diagnostic test in Africa. Importantly, an African-invented and designed test will be promoted. Indeed, innovation and the development of an African knowledge-based economy is a key priority of the EDCTP.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores